Berkeley Catalyst Fund overview
Berkeley Catalyst Fund contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
Job titleManaging Partner | LocationBay Area, United States | Email | |
Job titleAdvisor | LocationBay Area, United States | Email | |
Job titleFounding Partner | LocationBay Area, United States | Email | |
Job titleFounding Partner | LocationBay Area, United States | Email | |
Berkeley Catalyst Fund funds managed
Closed funds: 2
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size | Close dateJan 2023 | Strategy | |
Fund size | Close dateFeb 2017 | Strategy | |
Stories that mention Berkeley Catalyst Fund
Respiratory care developer Telesair snags $22m Series A
Pasaca Capital led the round.
4DMT reels in $90 mln Series B
4D Molecular Therapeutics, a gene therapy company, has raised $90 million in Series B Financing. Viking Global Investors led the round with participation from ArrowMark Partners, Janus Henderson Investors, The Biotechnology Value Fund, MiraeAsset Financial Group, Pappas Capital & Chiesi Ventures, Pfizer Ventures, Perceptive Advisors, Ridgeback Capital Investments, CureDuchenne Ventures and Berkeley Catalyst Fund.